Nanocarrier Company Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nanocarrier Company Limited with three other companies in this sector in Japan: DNA Chip Research, Inc. (2019 sales of 360.81 million Japanese Yen [US$3.32 million] ), Onco Therapy Science, Inc (280.59 million Japanese Yen [US$2.58 million] of which 73% was Research and Development of Pharmaceutic), and 3-D Matrix Ltd (328.85 million Japanese Yen [US$3.02 million] of which 100% was Medical Products).

Sales Analysis. During the year ended March of 2019, sales at Nanocarrier Company Limited were ¥496.73 million (US$4.56 million). This is an increase of 91.7% versus 2018, when the company's sales were ¥259.10 million. The sales level in 2019 was fairly close to the level five years ago: in 2014, Nanocarrier Company Limited had sales of ¥472.20 million.